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The cytokines IL-23 and IL-17 have been implicated in
resistance to cryptococcal disease, but it is not clear
whether IL-23–mediated production of IL-17 promotes
fungal containment following pulmonary challenge
with Cryptococcus neoformans. We used mice lacking
IL-23 (IL-23p19/) or IL-17RA (IL-17RA/), and wild
type (WT) C57BL/6 mice to examine the IL-23/IL-17 axis
after intranasal infection with the C. neoformans strain
52D. The absence of IL-23 or IL-17RA had no effect on
pulmonary or brain fungal burden at 1 or 6 weeks after
infection. However, survival of IL-23p19/ mice was re-
duced compared to IL-17RA/mice. IL-I7 production by
CD4Tcells andnatural killerT (NKT) cellswas impaired in
IL-23p19/ lungs, but was not completely abolished.
Both IL-23p19/ and IL-17RA/ mice exhibited im-
paired neutrophil recruitment, increased serum levels of
IgEand IgG2b, and increaseddepositionofYM1/YM2crys-
tals in the lung, but only IL-23p19/mice developed per-
sistent lung eosinophilia. Although survival of IL-17RA/
andWTmice was similar after 17 weeks of infection, only
surviving IL-17RA/mice exhibited cryptococcal dissem-
ination to the blood. These data demonstrate that IL-23
dampens the allergic response to cryptococcal infection
through IL-17–independent suppression of eosinophil re-
cruitment and IL-17–dependent regulation of antibody
production and crystal deposition. Furthermore, IL-23,
and to a lesser extent IL-17, contribute to disease
resistance. (Am J Pathol 2012, 180:1547–1559; DOI:
10.1016/j.ajpath.2011.12.038)
Cryptococcus neoformans is a fungal pathogen that
causes significant morbidity and mortality, primarily in
immunocompromised, but also in immunocompetent in-dividuals. In Africa, cryptococcal meningitis is the cause
of death of 20% to 30% of HIV-infected patients.1 Infec-
tion often occurs early in life when the organism is inhaled
from the environment.2,3 It is believed that most individ-
uals resolve acute pulmonary infection, but that yeasts
persist latently in granulomata.4–6 If the immune system
subsequently becomes compromised, the organism can
re-establish pulmonary infection and disseminate from
the lungs to the central nervous system.7,8 Depressed
CD4 T-cell–mediated immunity is associated with the
development of cryptococcal disease in HIV-infected in-
dividuals,9–11 but no biomarkers are available to predict
which individuals will develop disseminated disease, re-
gardless of CD4 counts, suggesting a complex immune
response is required for fungal containment.
Mousemodels of cryptococcal disease have established
that a TH1 polarized response is required for resolution of
primary infection,12–16 but innate15,17,18 and humoral19–21
factors also restrain fungal replication and facilitate the gen-
eration of adaptive T-cell–mediated immunity. Recent stud-
ies suggest a role for IL-17 in cryptococcal contain-
ment.22–27 The IL-17 family consists of the cytokines IL-
17a–f that are produced by innate cells such as lymphoid
tissue inducer,  T, NKT, alveolar macrophages, and neu-
trophils,27–31 as well as antigen-specific CD8 T cells32 and
TH17 cells.
33,34 IL-17a, IL-17f, and IL-17a/f heterodimers
signal through the IL-17RA/IL-17RC receptor complex to
induce antimicrobial peptide, cytokine, and chemokine pro-
duction,35–37 whereas IL-17e (IL-25) signals through IL-
17RA/IL-17RB to induce TH2 inflammatory responses.
38 IL-
17a and IL-17RA were shown to limit lung fungal burden in
mice infected with a genetically engineered, IFN-–produc-
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IFN- and IL-17 production and fungal clearance,22,27 cor-
roborating in vitro studies demonstrating that IL-17 can in-
hibit yeast replication within macrophages.39 In addition,
mice lacking IL-13 or both IL-4 and IL-13, produce in-
creased amounts of IL-17, which is associated with re-
duced burden in lungs.23,24
IL-17 production is enhanced by the cytokine IL-23.34,40,41
IL-23 is a heterodimeric cytokine composed of a unique sub-
unit, p19, and a shared subunit with IL-12, p40.42 IL-23 is
producedbydendritic cells ondectin-1 or dectin-2 recognition
of fungal antigens,43,44 and possibly Toll-like receptors since
bone-marrow–derived dendritic cells produce IL-23 in re-
sponse toC. neoformans in a MyD88-dependent manner.45 In
many infectionmodels, IL-23 contributes to disease resistance
in an IL-17–dependent manner.31,46–50 In a chronic, systemic
cryptococcal infection model, administration of recombinant
IL-23 increased production of IL-17 by TH17 cells and non-T
cells and prolonged survival,26 and lack of IL-23 impaired
immunity.25However, the role of IL-23 in the lungs in the setting
of respiratory acquisition of C. neoformans, the natural route of
infection, has not been examined.
We sought to determine whether IL-23 promotes IL-17
production and subsequent control of chronic pulmonary
infection caused by C. neoformans, strain 52D. Using
IL-23p19/ or IL-17RA/mice, we found that IL-23 and
IL-17 did not significantly contribute to control of lung
fungal burden or yeast dissemination to the brain during
the first 6 weeks of infection, but the absence of IL-23 was
associated with increased mortality. IL-23 and IL-17 both
suppressed mediators of the allergic response to C. neo-
formans; specifically IgE production and the formation of
YM1/YM2 crystals; however, IL-23 also inhibited eosino-
phil recruitment to the lung.
Materials and Methods
Mice
Male 6- to 8-week-old C57BL/6 WT control mice were
purchased from the National Cancer Institute (Charles
River Laboratories, Wilmington, MA). IL-23p19/ mice
were obtained from Genentech (San Francisco, CA), and
IL-17RA/ mice were supplied by Amgen (Seattle, WA).
IL-23p19/ and IL-17RA/ mice were previously back-
crossed 10 generations onto the C57BL/6 background and
were bred under pathogen-free conditions in the Institute for
Animal Studies at the Albert Einstein College of Medicine
(AECOM). All mice were given unrestricted access to food
and water. All mouse experiments were conducted with
prior approval from the Animal Care and Use Committee of
AECOM following established guidelines.
Cryptococcal Infection Model
A serotype D strain (52D) of C. neoformans, ATCC 24067
(American Type Culture Collection, Manassas, VA), was
used for intranasal (i.n.) infection of mice. Strain 52D has
been used extensively to evaluate the immune response
to experimental pulmonary cryptococcosis.25,51–54 The
C. neoformans strain was kept in 15% glycerol aliquots at80°C until needed. Thawed aliquots of C. neoformans
were grown in Difco Sabouraud Dextrose Broth (Becton
Dickinson, Franklin Lakes, NJ) for 48 hours at 37°C with
shaking, washed twice in PBS (Mediatech, Herndon, VA),
and counted in a hemocytometer using Trypan Blue for
viability. For the i.n. infection, mice were anesthetized
with isoflurane (Halocarbon, River Edge, NJ) and placed
in a vertical position. A volume of 20 L containing 5 
105 colony-forming units (CFU) of C. neoformans was
administered via the nares. For survival studies, infected
mice were observed at least once daily.
Measurement of Tissue and Blood Fungal
Burden
Blood was collected from three to five animals per group
by retro-orbital puncture under deep isoflurane anesthe-
sia. After blood collection, mice were euthanized by cer-
vical dislocation. Lungs and brains were removed and
homogenized in 1 mL of HBSS (Lonza, Walkersville, MD).
CFU were determined by making 10-fold serial dilutions
of each tissue or twofold dilutions of blood and plating 20
L of the sample and dilutions on Sabouraud Dextrose
agar plates (BBL, Sparks, MD). Each sample was pro-
cessed in duplicate. Plates were incubated at room tem-
perature for 72 hours, after which colonies were visually
counted.
Measurement of Cytokine Levels
Lung homogenates that were used to determine fungal
burden were centrifuged at 3000  g for 30 minutes at
4°C and the supernatants collected. The supernatants
were centrifuged at 13,000 g at 4°C for an additional 10
minutes to remove any remaining debris. Samples were
stored at 80°C before use. All cytokine concentrations
were determined using a DuoSet ELISA Development Kit
(R&D Systems, Minneapolis, MN) according to the man-
ufacturer’s protocol.
Isolation of Lung Cells
In independent experiments, three to five mice per group
were anesthetized with isoflurane, sacrificed by cervical
dislocation, and lungs removed. Single-cell lung suspen-
sions were obtained from using a gentleMACS Dissocia-
tor (Miltenyi Biotec, Auburn, CA) following the manufac-
turer’s protocol for dissociation of mouse lung. Briefly,
lungs were excised, washed in PBS, and added to gen-
tleMACS Dissociator C tubes containing 5 mL of HEPES
buffer, 2 mg/mL Collagenase D, and 40 U/mL DNase I
(Roche, Indianapolis, IN). Lungs were briefly dissociated
using the gentleMACS, incubated for 30 minutes at 37°C
for tissue digestion, and then further dissociated with the
gentleMACS to obtain a single-cell suspension. Red
blood cells were lysed by addition of 0.17 mol/L NH4Cl
(Sigma-Aldrich, St. Louis, MO), and the lung homogenate
was passed through 70-m filters (BD Biosciences, San
Jose, CA) to remove debris.
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The phenotypes of isolated lung cells were determined
by flow cytometry. Before staining for cell-surface mark-
ers, cells were incubated with CD16/32 in 1% bovine
serum albumin–PBS for 10 minutes at 4°C to limit non-
specific binding. Cells were then stained for 15 minutes
at 4°C with combinations of the following antibodies:
CD45-Pacific Blue or Alexa 700, Ly6G-APC-Cy7, CD11b-
Percp-Cy5.5, or APC-Cy7, CD11c-Pe-Cy7, MHCII-Pe,
Ly6C-FITC, F4/80-Alexa 647, CD19-Pe-Cy7, B220-Percp-
Cy5.5, IgD-Alexa 647, IgM-FITC, CD5-PE, CD49b-APC,
CD4-APC-Cy7, CD8-Pacific Blue, CD3-Alexa 647. Anti-
bodies were purchased from BD Biosciences (Franklin
Lakes, NJ) with the exceptions of F4/80-Alexa 647 and
CD11b-Percp-Cy5.5 (eBioscience, San Diego, CA), and
CD45-Pacific Blue (Biolegend, San Diego, CA). Appro-
priate fluorescence minus one and isotype controls were
also included. Data were collected on an LSRII (BD Bio-
sciences) and analyzed with FlowJo software (Tree Star,
Ashland, OR).
Calculation of the Number of CD45 Lung
Leukocytes
Isolated mammalian lung cells and extracellular yeast
were counted using a Scepter handheld automated cell
counter (Millipore, Billerica, MA). Cells ranging from 6 to
24 m in size were included in the cell count, with 90%
of the cells being between 6 and 14 m. To arrive at the
number of CD45 lung leukocytes, the relative percent-
age of live lung cells as determined by forward and side
scatter and CD45 double gating was multiplied by the
automated Scepter cell count, therefore excluding yeast
and CD45 mammalian leukocytes.
Intracellular Staining for IL-17a
A Lympholyte M (Cedarlane, Ontario, Canada) gradient
was used for enrichment of CD45 leukocytes from lung
cell suspensions. Isolated leukocytes were plated in 96-
well plates at a concentration of 1 106 lung cells/200 L
of RPMI-10% bovine serum albumin. The lung cells were
stimulated for 5 hours at 37°C with 50 ng/mL PMA, 1
g/mL ionomycin (Sigma-Aldrich), and 1 L of GolgiPlug
(BD Biosciences). Leukocytes were washed and stained
with LIVE/DEAD Fixable Violet Dead Cell stain (Invitro-
gen, Carlsbad, CA) for live-cell gating followed by stain-
ing with surface antibodies as described above. Leuko-
cytes were then permeabilized in Cytofix/Cytoperm, and
stained in Permwash buffer with anti–IL-17a-PE (BD Bio-
sciences) at a 1:100 dilution for 30 minutes at 4°C.
Determination of Serum Antibody
Concentrations
Concentrations of serum antibodies were determined by
enzyme-linked immunosorbent assay as described pre-
viously.55 EIA/RIA 96-well plates (Costar, Corning, NY)
were coated with 10 g/mL of goat anti-mouse IgM orIgG (SouthernBiotech, Birmingham, AL) or 2 g/mL rat
anti-mouse IgE (BD Biosciences) for 1 hour at 37°C.
Plates were then blocked overnight with 1% bovine se-
rum albumin–PBS (Sigma-Aldrich, St. Louis, MO) and
washed with PBS-Tween 20 using an Aquamax 2000
plate washer (Molecular Devices, Bethesda, MD) before
use. Serum was added at a dilution of 1:5 for IgE, 1:15 for
total IgM, and 1:1000 for total IgG and IgG isotypes, and
serially diluted 1:3 with 1% bovine serum albumin–PBS.
Mouse IgM and IgG (SouthernBiotech) and IgE (BD Bio-
sciences) standards were applied at a starting concen-
tration of 10 g/mL for IgM and IgG and 1 g/mL for IgE.
Samples and standards were incubated for 1 hour at
37°C, plates were washed, and then antibody detected
with a 1:2500 dilution of goat anti-mouse IgM, IgG, IgG1,
IgG2b, IgG2c, or IgG3 or 1:1000 dilution of goat anti-
mouse IgE for 1 hour at 37°C. Plates were subsequently
developed with 1 mg/mL p-nitrophenyl phosphate (Sigma-
Aldrich) dissolved in bicarbonate buffer (pH 9.8). A titra-
tion curve was generated by curve-fit analysis using
GraphPad Prism 5 software (San Diego, CA). The titer for
IgG subtypes was defined as the point at which the
titration curve crossed an optical density of 0.1 after
subtraction of the background.
Determination of GXM-Specific IgM and IgG
Plates were coated with 10 g/mL C. neoformans 24067
GXM for 3 hours at room temperature and processed as
described.55 Briefly, serum samples were added at start-
ing dilution of 1:5 and serially diluted. GXM-specific an-
tibody was detected by addition of goat anti-mouse IgM
or IgG, plates were developed, and the titer determined
as described above.
Histology
At 7, 42, and 123 days after infection, groups of three to
four mice were anesthetized with isoflurane, sacrificed by
cervical dislocation, and lungs and brains removed. Tis-
sues were fixed in 10% neutral buffered formalin (Fisher
Scientific, Pittsburgh, PA). Following 48 to 72 hours of
fixation, samples were sent to the Histopathology Core of
AECOM for routine processing into paraffin blocks. Five-
micrometer lung and brain tissue sections were routinely
stained with H&E and examined under a Zeiss AxioScope
II microscope (Carl Zeiss, Thornwood, NY) by a board-
certified veterinary pathologist (R.S.S.).
Statistical Analysis
Mouse survival data were evaluated by comparing Ka-
plan-Meier survival curves with a log-rank (Mantel-Cox)
test. For experiments in which only WT and IL-23p19/
mice were compared, a Student’s t-test was applied. For
multiple comparisons between groups of WT, IL-
23p19/, and IL-17RA/ mice, data that exhibited
equal variance and equal normality were analyzed for
significance by one-way analysis of variance followed by
Holm-Sidak post-test. For data that did not exhibit equal
variance and normality, a Kruskal-Wallis rank-based one-
s (B). Re
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Dunn’s post-test. A P value of 0.05 was considered
significant. All statistical tests were performed using the
advisory statistical software, SigmaStat 3.0 (SyStat, San
Jose, CA).
Results
Tissue Fungal Burden in IL-23p19/ and
IL-17RA/ Mice
Previous studies have demonstrated impaired fungal
clearance and reduced survival of IL-23p19/ mice in-
fected intraperitoneally or intravenously with C. neofor-
mans, which was associated with reduced production of
IL-17.25 We sought to expand on these studies by deter-
mining whether IL-23 or IL-17 also contributes to control
of pulmonary burden and/or yeast dissemination to the
brain in an intranasal infection model of chronic crypto-
coccosis.56 IL-23p19/, IL-17RA/, and C57BL/6 WT
mice were infected intranasally with 5  105 CFU of C.
neoformans strain 52D, and the fungal burden in lungs,
brain, and blood evaluated at days 7 and 42 after infec-
tion. Fungal burden in lungs of IL-23p19/ or IL-
17RA/ mice were similar (P  0.05) to WT at both time
points examined (Figure 1A). No yeast was cultured (50
CFU/mL) from the brain at day 7 or in blood at day 7 or
day 42 from any WT, IL-23p19/, or IL-17RA/ mice
(n  9 to 15). At day 42 after infection, the mean brain
fungal burden was statistically comparable (P  0.05) in
all groups of mice (Figure 1A).
We evaluated the survival of IL-23p19/, IL-17RA/,
and WT mice. Although C57BL/6 mice can initially con-
tain infection caused by strain 52D, the TH2-dominated
allergic response to the fungus promotes yeast dissem-
ination and death.12,51 Survival 13 weeks post-infection
was only 23% in IL-23p19/ mice, whereas 83% of
IL-17RA/ and 75% of WT mice were alive at week 13
(Figure 1B). The decreased survival of IL-23p19/ mice
was significant (P 0.05) compared to IL-17RA/mice,
and there was a trend toward significance (P  0.1)
A
Figure 1. IL-23 and IL-17RA do not significantly contribute to reduction in
in lungs and brains (as labeled) was determined at the indicated time poin
independent experiments. Survival of IL-23p19/ and C57BL/6 WT control
n  6 (WT, IL-23p19/, and IL-17RA/).compared to WT (Figure 1B).Measurement of Lung Cytokines
IL-17 is produced in response to IL-23,26,50,57 as well as
other stimuli.30,34,41,58,59 We asked whether IL-23 was
required for IL-17 production during C. neoformans infec-
tion. IL-17 levels were increased in both WT (P  0.001)
and IL-23p19/ (P  0.01) lungs at day 7 after infection
compared to naive WT and IL-23p19/ mice, respec-
tively, but IL-17 was lower (P  0.01) in IL-23p19/ and
IL-17RA/ lungs at day 7 compared to WT (Figure 2).
At day 42, there was no difference (P  0.05) in IL-17
levels between WT and IL-23p19/ lungs (Figure 2).
We also examined other cytokines that can be regu-
lated by IL-23/IL-17 and/or influence cryptococcal con-
tainment,13,16,28,35,51,56,60 but we did not find differences
(P 0.05) in levels of IL-4, IL-5, IL-13, IL-12, IFN-, IL-10,
TGF-, or IL-6 (Figure 2).
To identify leukocytes that were producing IL-17 in WT
and IL-23p19/ mice, we performed intracellular stain-
ing for IL-17a followed by flow cytometry. We found that
95% of the IL-17a–producing leukocytes in the lungs of
WT and IL-23p19/ mice were CD3 (Figure 3, A and
B), whereas no CD11b cells were IL-17a (Figure 3A).
Further analysis revealed that the IL-17a cells were pri-
marily composed of CD3CD4 T cells and
CD3CD49b NKT cells (Figure 3, A and B). The per-
centage of CD45 leukocytes producing IL-17a was sim-
ilar (P 0.05) between WT and IL-23p19/mice (Figure
3C), as well as the absolute number (mean 104 SEM,
n  5) of IL-17a leukocytes (WT: 3.00  0.22, IL-
23p19/: 3.28  0.22), but the median fluorescent in-
tensity of the IL-17a cells was decreased (P  0.01) in
IL-23p19/ compared to WT (Figure 3D).
Cellular Inflammation in Lungs
IL-23–mediated IL-17 production enhances neutrophil
and monocyte recruitment to sites of inflamma-
tion,33,37,61,62 therefore, we assessed lung leukocyte
phenotype in IL-23p19/, IL-17RA/, and WT mice be-
fore and after 7 and 42 days of infection by flow cytom-
B
rmans CFU, but survival of IL-23p19/ mice is decreased. Fungal burden
nfection (A), (n  9 to 20). Error bars represent the SEM from two to four
sults are from two independent experiments, n  6 (WT and IL-23p19/),C. neofo
ts after ietry. The number of CD45 lung leukocytes was similar
mice or
01 versu
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(Table 1). However, there were differences in the propor-
tions of leukocyte populations. Naive IL-17RA/ and
IL-23p19/ mice exhibited an increase (P  0.001, P 
0.01, respectively) in CD3CD8 T cells in lungs com-
pared to WT (Figure 4). There were also more (P 0.001)
CD3CD49b NKT cells in naive IL-17RA/ lungs com-
pared to WT (Figure 4). At day 7 after infection,
SiglecFCD11cSSChi eosinophils were increased (P 
0.001) in lungs of IL-23p19/ mice compared to WT,
whereas IL-17RA/ lungs contained more (P  0.001)
CD3CD4 T cells and NKT cells (Figure 4). At day 42,
eosinophils remained increased (P  0.001) in IL-
23p19/ lungs, and CD11bCD11cF4/80 macro-
phages were decreased (P  0.001) compared to WT.
L L
L L
L L
Figure 2. The absence of IL-23 or IL-17RA results in decreased IL-17 levels
Lung homogenates were used to quantitate cytokine production in naive
***P  0.001 versus WT D7; ††P  0.01 versus IL-23p19/ naive; †††P  0.0Ly6GhiCD11b neutrophils were diminished in both IL-23p19/ (P  0.05) and IL-17RA/ lungs (P  0.01)
compared to WT at day 42 (Figure 4). There was no
difference (P  0.05) in numbers of CD11chiCD11blo
alveolar macrophages, CD11cCD11b dendritic cells,
CD11cCD11bLy6Chi monocytes, CD49bCD3 NK
cells, or CD19B220hi B cells between the strains at any
time point (data not shown).
Antibody Response
Lung eosinophil influx is enhanced by IgE,63 and both
eosinophil recruitment and IgE production are associated
with cryptococcal disease susceptibility.13,64 We found
that serum IgE was significantly increased (P  0.05) in
naive IL-17RA/ mice (Figure 5A) and at day 7 in IL-
L
L
L
early after infection but has no influence on production of other cytokines.
7 days (D7) and 42 days (D42) after infection (n  3 to 8). **P  0.001,
s WT naive mice. Error bars represent the SEM of one to two experiments.in lungs23p19/ and IL-17RA/ mice compared to WT, but at
4 T ce
a cells
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strains (P  0.05) (Figure 5).
In contrast to IgE, secretion of IgM and antigen-spe-
cific IgG can contribute to resistance to cryptococco-
sis.19–21,65 Total serum IgM concentration did not differ
(P  0.05) between IL-23p19/, IL-17RA/, and WT
mice, but total serum IgG was significantly elevated in
naive IL-17RA/ and in both IL-23p19/ and IL-
17RA/ mice compared to WT at day 7 and day 42 after
infection (Figure 5A). We determined the titer of specific
IgG isotypes and found that serum titers of IgG2b were
increased (P  0.001) in IL-23p19/ and IL-17RA/
mice at day 7 compared to WT, whereas differences in
A
B C
Figure 3. CD4T and NKT cells in lungs of IL-23p19/ mice produce decrea
were isolated from WT (top panels) and IL-23p19/ (bottom panels) mice
represent the percentage of CD45IL-17a cells that were CD3, CD3CD
producing IL-17a (C); and median fluorescent intensity (MFI) of CD3IL-17
Table 1. Lung CD45 Leukocytes
Day 0 Day 7 Day 42
WT 1.53  0.05* 3.09  0.06 5.46  0.12
IL-23p19/ 1.61  0.40 3.04  0.10 5.62  0.20
IL-17RA/ 1.41  0.35 3.93  0.25 5.85  0.51*Mean number of CD45 leukocytes  SEM  105, (n  4 to 9).IgG1, IgG2c, and IgG3 were not significant (P  0.05),
(Figure 5B). Despite the increase in total serum IgG in
both IL-23p19/ and IL-17RA/ mice at day 7, titers of
anti-cryptococcal GXM were only significantly elevated
(P  0.01) in IL-17RA/ mice (Figure 5C).
Histopathology of Lungs and Brains
Eosinophil recruitment to the lungs of C57BL/6 mice in-
fected with C. neoformans results in deposition of Char-
cot-Leyden–like crystals, resulting in tissue damage.51
These crystals are composed of the chitinases YM1 and
YM2 that are produced by alternatively activated macro-
phages; therefore, it is hypothesized that eosinophils in-
duce crystal formation by influencing macrophage acti-
vation.56,66,67 Lung sections from C. neoformans–infected
mice were examined by H&E staining to determine
whether the increased eosinophilia in IL-23p19/ mice
was associated with amplified lung pathology. On day 7
after infection, there was no significant difference in lung
D
unts of IL-17 compared to WT mice. At day 7 post-infection, lung leukocytes
racellular production of IL-17a was assessed by flow cytometry (A). Graphs
lls, or CD3CD49b NKT cells (B); percentage of CD45 lung leukocytes
(D), (n  5). *P  0.05 versus WT.sed amo
, and int
pathology between IL-23p19/, IL-17RA/, and WT
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increased amounts of acidophilic YM1/YM2 crystals in
lungs of both IL-23p19/ and IL-17RA/ mice (Fig-
ure 6, Table 2). The inflammation was primarily eosino-
philic and neutrophilic except in the WT mice, which had
notably more neutrophilic inflammation. In the WT mice,
the neutrophils were generally associated with focal tis-
sue destruction (Table 2). We also examined brain sec-
tions at day 42 after infection, but there were no notable
differences in cryptococcal burden or inflammatory infil-
trate (Table 2).
After 17 weeks of infection (day 123), four of five sur-
viving WT mice displayed little granulomatous inflamma-
tion in lungs (Figure 7, A–D, Table 3), and one WT mouse
exhibited minimal to mild acidophilic macrophage pneu-
monia with YM1/YM2 crystals (Table 3). Cryptococci
were not apparent in lungs of any WT mice (Table 3). By
contrast, all IL-17RA/ mice (n  4), exhibited acido-
Figure 4. Eosinophils are increased in lungs of infected IL-23p19/ mice,
whereas CD4 T and NKT cells are increased in lungs of infected IL-17RA/
mice. Lung cells were analyzed by flow cytometry to determine the relative
percentages of the indicated leukocyte populations after gating on CD45
cells in WT, IL-23p19/, and IL-17RA/ lungs before and during infection
(n  4 to 9). *P  0.05, **P  0.01, and ***P  0.001versus WT. Data
represent the mean  SEM of one to two experiments.philic macrophage pneumonia in lungs, ranging frommild to severe, with cryptococci. Cryptococcal foci con-
tained mild numbers of eosinophils and aggregates of
fragmented neutrophils that were associated with necro-
sis, presumably resulting from tissue damage from
pointed YM1/YM2 crystals (Figure 7, A–D, Table 3).
The brains of WT mice at week 17 had focal areas of
chronic inflammation with no typical cryptococcal organ-
isms (Table 3). Two of four IL-17RA/ mice had similar
inflammatory infiltrates, with one containing aggre-
gates of viable-appearing organisms. Cryptococci
were cultured from the blood of IL-17RA/ mice at
week 17, but were below the detection limit (50 CFU/
mL) in WT (Figure 7E).
Discussion
Our findings reveal IL-17–independent and -depen-
dent roles of IL-23 in limiting the allergic response
during chronic pulmonary cryptococcal disease. Al-
though IL-23 was not required for induction of IL-17, it
enhanced IL-17 production by NKT and CD4T cells
during early cryptococcal infection. Both IL-23 and
IL-17 suppressed serum IgE, IgG2b, and formation of
pulmonary YM1/YM2 crystals, suggesting that IL-23–
dependent production of IL-17 contributes to control of
cryptococcal-induced allergy. However, an IL-17–in-
dependent function of IL-23 was also evident, since
IL-23p19/ mice had increased numbers of eosino-
phils in the lung at all time points after cryptococcal
infection. This was in sharp contrast to IL-17RA/ and
WT mice, which did not exhibit these findings. Based
on these data, pulmonary eosinophilia might promote
mortality, because IL-23p19 null mice had higher mor-
tality than IL-17 mutant mice, despite having a similar
cryptococcal burden in lung and brains.
Cryptococcal infection in C57BL/6 mice results in a
TH2-dominated response that is accompanied by allergic
markers that are similar to those observed in humans with
allergic bronchopulmonary mycosis.68,69 Although our
data indicates that IL-23 dampens the allergic broncho-
pulmonary mycosis phenotype of C. neoformans–infected
mice, IL-23 enhanced allergic lung inflammation and eo-
sinophilia in experimental models of ovalbumin-induced
asthma in C57BL/6  129 and BALB/c mice.70,71 The
contrast between the roles of IL-23 in cryptococcal ver-
sus ovalbumin-induced allergy suggests that cryptococ-
cal antigens drive an allergic response that is unique
from that of ovalbumin-induced allergy and in which IL-23
is immunoregulatory. In support of this hypothesis, recent
work has demonstrated that the mechanisms of eosino-
phil recruitment induced by fungal chitin and ovalbumin
are distinct.72 Furthermore, an immunoregulatory role for
IL-23 and IL-17a has been indicated in chronic asthma
induced by Aspergillus fumigatus or house dust mite an-
tigen. Lung inflammation is exacerbated in asthmatic
TLR6 null mice as a result of decreased IL-23 production,
and IL-17a inhibits goblet cell metaplasia in asthmatic
C57BL/6 mice.73 Taken together, these studies indicate
that the role of IL-23 and IL-17 signaling in the lung is
ccal GX
rom one
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AJP April 2012, Vol. 180, No. 4complex, and likely dependent on many immune factors
that are modulated by exogenous antigens.
Eosinophils are held to be deleterious in the mouse
model of cryptococcosis. Early studies demonstrated
A
B
Figure 5. IgG and IgE is elevated in serum of IL-23p19/ and IL-17RA/ m
of serum IgG isotypes 7 days after infection (B), and titers of serum cryptoco
**P  0.01, and ***P  0.001 versus WT. Data represent the mean  SEM f
A B
C D
E F
Figure 6. IL-23p19/ and IL-17RA/mice exhibit increased YM1/YM2 crys-
tal formation in lungs during chronic infection compared to WT. Representative
H&E-stained lung sections from WT (A and B), IL-23p19/ (C and D), and
IL-17RA/ (E and F) 42 days after infection (n 3 to 4). Large arrowheads
designate YM1/YM2 crystals, and small arrows indicate eosinophils. Orig-
inal magnification: 10 (A, C, and E); 40 (B, D, and F).that IL-5–dependent eosinophil recruitment results in
crystal formation in macrophages and lung damage.51
More recent work, using mice that lack eosinophils, con-
firm these findings and demonstrate decreased fungal
burden in the absence of eosinophils.74 These findings
contrast with those in rat models of cryptococcosis, in
which primary infection can resolve and eosinophils
contribute to a protective TH1 response.
75,76 Our data
support a destructive role for eosinophils, possibly by
promoting tissue damage and subsequent mortality of
IL-23p19/mice. Eosinophilic granule proteins are toxic
to bystander cells, resulting in lung damage,77 and con-
tribute to airway constriction and impaired respiration.78
Additional deleterious functions of eosinophils were dem-
onstrated in an Aspergillus-induced allergic asthma
model, in which mice lacking eosinophils or CCR3, an
eosinophil chemokine receptor, displayed reduced mu-
cous production and decreased transcription of genes
involved in coagulation.79
Similar to our data, survival of IL-23p19/ mice in-
fected intraperitoneally or intravenously with C. neofor-
mans strain 1841D is decreased.25 In the foregoing sys-
temic infection model, the absence of IL-23 resulted in
increased hepatic fungal burden and decreased infiltra-
tion of inflammatory cells into the brain, but not increased
brain fungal burden.25 We could not attribute the in-
creased mortality of IL-23p19/ mice infected intrana-
sally with C. neoformans-52D to increased brain or lung
fungal burden or differences in brain inflammation. How-
ever, we did find that their earlier time to death was
associated with a higher number of lung eosinophils. One
explanation for the increased mortality of IL-23p19/
ncentration of serum IgE, IgM, and IgG at the indicated time points (A), titers
M-specific IgM and IgG 7 days after infection (C), (n  5 to 10). *P  0.05,
to two experiments.C
ice. Comice in our model is that in combination, lung eosinophils
osinoph
25% t
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AJP April 2012, Vol. 180, No. 4and YM1/YM2 crystals could impair respiration, whereas
crystals without increased eosinophils do not impact pul-
monary physiology in IL-17RA/mice. Although alveolar
accumulation of needle-shaped YM1/YM2 crystals can
induce mechanical damage, lung consolidation, insuffi-
Table 2. Histopathology of Lungs and Brains 42 Days after Infec
Brain
Mouse number 1 2
Cryptococcal nodules* 3 0
With pyogranulomatous inflammation* 2 0
Infiltrate, perivascular, chronic* 1 0
Lung
Mouse number 1 2
Granulomatous pneumonia† (# lobes/5)
Minimal 0 0
Mild 0 0
Moderate 1 3
Marked 1 2
Severe 3 0
Acidophilic crystalline material‡ 1 2
Neutrophils in inflammation‡ 3 3
*Severity modifiers: 0  no lesion, 1  minimal lesion, 2  mild lesio
†Granulomatous pneumonia refers to dense pyogranulomatous and e
‡Pneumonia severity modifiers: 1  1% to 10%, 2  10% to 25%, 3 
A B
C
E
D
Figure 7. Surviving IL-17RA/mice display acidophilic macrophage pneu-
monia and fungal dissemination to the blood after 17 weeks of infection.
Representative H&E-stained lung sections from WT (A and B) and IL-
17RA/ mice (C and D), (n  4 to 5). Fungal burden (Log10 CFU/mL) in
/blood of WT and IL-17RA mice (E), (n  4 to 5). Original magnification:
10 (A and C); 40 (B and D). KO, knockout.cient respiration, and fatality without eosinophilia,66,80,81
comparable crystal formation in the lungs of IL-23p19/
and IL-17RA/ mice suggests that additional factors,
such as lung-damaging eosinophils, could have contrib-
uted to respiratory demise and mortality in infected-IL-
23p19/ mice.
Eosinophil recruitment to lungs can be mediated by
CD4 T-cell production of TH2 cytokines.
23,51,82 Although
the increase in lung eosinophils in IL-23p19/ mice was
not accompanied by an increase in lung levels of IL-5,
IL-4, or IL-13, it is possible that non–T-cell sources
masked a decrease in CD4 T-cell production of one or
more of these cytokines in whole-lung homogenates. At
present, it is not known whether the cellular source and/or
the location of TH2 cytokine production are important
factors in eosinophil emigration into the lung during cryp-
tococcal infection. Given that ligation of Ox40, a T-cell–
activating receptor, on CD4 T cells limits eosinophil re-
cruitment in an IFN-–dependent manner during
cryptococcal infection, signaling via OX40 could be de-
creased in IL-23p19/ mice.83 Alternatively, eosinophil
generation and release from bone marrow or migration
from the circulation into the lung could be mediated by
other factors. However, we found that transcription of
eotaxin, an eosinophil chemoattractant that can promote
eosinophil recruitment,84 was not increased in lungs of
IL-23p19/ mice at day 7 or 21 after infection (data not
shown). Furthermore, we note that the increase in eo-
sinophils in lungs of IL-23p19/ mice could reflect a
defect in eosinophil clearance, rather than an increase
in eosinophil recruitment. Though not specific to eosin-
ophils, IL-23 was recently shown to inhibit cellular in-
filtration into the lungs in an A. fumigatus allergy
model,73 but the mechanism was not examined. There-
fore, more work is needed to determine how IL-23
directly or indirectly inhibits eosinophil recruitment in
fungal infections.
IgE secretion during cryptococcal infection is associ-
ated with reduced lung function.64 It appears that IL-23
IL-23p19/ IL-17RA/
4 1 2 3 1 2 3 4
1–2 1 1 2 1 1 1 2
0 0 0 0 0 0 0 2
1 0 0 1 1 1 0 0
4 1 2 3 1 2 3 4
0 0 0 0 0 0 1 1
1 0 0 0 2 2 4 4
3 3 1 1 2 2 0 0
1 2 2 3 1 1 0 0
0 0 2 1 0 0 0 0
2 3 4 4 4 4 4 2
2 1 1 1 1 1 1 1
oderate lesion, 4  marked lesion, 5  severe lesion.
ilic inflammation.
o 45%, 4  45% to 75%, 5  75%.tion
WT
3
1–2
0
0
3
0
0
1
4
0
1
3
n, 3  mand IL-17RA restrain IgE production, since IgE was ele-
osinoph
mposed
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tion. Increased IgE levels also occurred in naive IL-
17RA/ mice. To our knowledge, elevated IgE has not
been reported in naive IL-17RA/ mice. To confirm that
increased IgE was not a response to parasites,85 the
cecum and colon were evaluated histologically to confirm
the lack of intestinal parasites, and sentinel mice were
routinely verified to be parasite free. Interestingly, a link
between IL-23/IL-17 and IgE regulation is also seen in
humans. Individuals with hyper-IgE syndrome exhibit a
genetic mutation in STAT3 that results in impaired IL-23
and IL-17 production; however, the cause of the elevated
IgE is not known. These individuals also have increased
susceptibility to infections by the fungi Candida and
Aspergillus, as well as to various bacteria.86–89
In addition to elevated IgE, the absence of IL-23 and
IL-17RA resulted in increased serum IgG, primarily
IgG2b. Elevated total serum IgG in naive IL-17RA/
mice and IgG2b after Porphyromonas gingivalis has also
been reported.90 It is not clear from our studies whether
the increase in IgG in IL-23p19/ mice or IL-17RA/
has any effect on immunity. Previous studies have dem-
onstrated that GXM-specific IgG2b can have protective
functions in mice infected with a lethal dose of C. neofor-
mans,91,92 but IgG2b has also been shown to be a
weaker opsonin than IgG2a and IgG1,93 and is associ-
ated with decreased survival time when administered to
mice before cryptococcal infection in comparison to
other antibody isotypes.91,94,95 Another possibility is that
the elevated IgG to IgM ratio in IL-23p19/ and IL-
17RA/ mice impacts binding of IgM, which is diluted
by the excess IgG. Secreted IgM promotes phagocytosis
of C. neoformans, inflammation, and granuloma formation
that is associated with disease resistance.20
Although the absence of IL-17RA did not impact mor-
tality up to 17 weeks, our data suggest that IL-17 con-
tributes to disease resistance by limiting dissemination of
Table 3. Histopathology of Lungs and Brains of Surviving WT an
Brain
Mouse number 1 2
Cryptococcal nodules* 0 0
Granulomatous inflammation* 0 0
Infiltrate, perivascular, chronic* 0 0
Lung
Mouse number 1 2
Granulomatous pneumonia† (# lobes/5)
No lesions 4 0
Minimal 1 5
Mild 0 0
Acidophilic
Macrophage pneumonia‡
No lesions 0 1
Minimal 0 2
Mild 0 2
Moderate 0 0
Marked 0 0
Severe 0 0
*Severity modifiers: 0  no lesion, 1  minimal lesion, 2  mild lesio
†Granulomatous pneumonia refers to dense pyogranulomatous and e
‡Acidophilic macrophage pneumonia refers to dense inflammation coyeast to the blood late in infection. The presence of cryp-tococci in blood of IL-17RA/ mice correlated with in-
creased acidophilic YM1/YM2 crystal deposition in lungs,
which progressed between weeks 6 and 17 after infec-
tion. A role for IL-17 late in infection is also demonstrated
in a vaccination model in which C. neoformans-H99, a
-interferon–producing H99 strain, elicits protection from
subsequent infection of BALB/c mice with H99.27,96 IL-17
is not required for survival, but vaccinated IL-17RA/
mice exhibited dissemination to the brain after rechal-
lenge, indicating protective functions of IL-17.27 How-
ever, our findings contrast with this vaccination model, in
which IL-17RA also contributed transiently to control of
pulmonary burden.27 We found that lung cryptococcal
burden was similar between WT and IL-17RA/ mice at
day 7 and day 42 after infection, suggesting that there
are compensatory pathways that can sufficiently control
fungal burden during early infection of C57BL/6 mice with
cryptococcal strain 52D. IL-17RA/ lungs did contain
elevated numbers of CD8T and NKT cells before infection
and CD4T and NKT cells at day 7 after infection, and
these cellular effectors are known to contribute to cryp-
tococcal disease resistance.9,97,98
Although our studies did not address a potential dele-
terious role of the IL-23/IL-17 axis, it is important to note
that IL-17 is also associated with cryptococcal disease
susceptibility. Increased production of IL-17 by alveolar
macrophages is associated with accelerated mortality in
mice challenged with a highly virulent mucoid strain of C.
neoformans99 or in mice lacking secretory IgM.20 Also,
increasing IL-17 levels are associated with mortality in
HIV patients with immune reconstitution syndrome follow-
ing cryptococcal meningitis.100 Future studies are
needed to understand whether yeast virulence factors,
the timing of IL-17 production, the cellular sources of
IL-17, or additional host factors influence the outcome of
IL-17 signaling.
The findings presented herein provide evidence that
7RA/ Mice 123 Days after Infection
WT IL-17RA/
3 4 5 1 2 3 4
0 0 0 0 0 0 3
0 2 0 0 2 0 2
0 0 0 0 1 0 2
3 4 5 1 2 3 4
5 0 3 4 5 4 3
0 3 2 1 0 1 0
0 2 0 0 0 0 2
0 0 0 2 2 4 2
0 0 0 0 0 1 1
0 0 0 0 0 0 0
0 0 0 0 3 0 2
0 0 0 1 0 0 0
0 0 0 2 0 0 0
oderate lesion, 4  marked lesion, 5  severe lesion.
ilic inflammation.
of macrophages with acidophilic YM1/YM2 crystals.d IL-1
n, 3  mIL-23 and IL-17 may contribute to disease resistance by
The Role of IL-23 in Cryptococcosis 1557
AJP April 2012, Vol. 180, No. 4limiting the allergic response to cryptococcal infection.
Since IL-23 has opposing effects in non-fungal allergy
models,70,71 it will be important to further examine IL-23
signaling in specific IL-23–responsive leukocyte popula-
tions and determine how cryptococcal antigen and host
factors influence IL-23 activity.
Acknowledgments
We thank the AECOM Flow Cytometry Core Facility under
the support of the AECOM National Cancer Institute
(P30CA013330) for assistance with data acquisition.
References
1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG,
Chiller TM: Estimation of the current global burden of cryptococcal
meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525–
530
2. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski L, Niang R,
Casadevall A: serologic evidence for Cryptococcus neoformans
infection in early childhood. Pediatrics 2001, 107:E66
3. Abadi J, Pirofski L: Antibodies reactive with the cryptococcal cap-
sular polysaccharide glucuronoxylomannan are present in sera from
children with and without human immunodeficiency virus infection.
J Infect Dis 1999, 180:915–919
4. Saha DC, Goldman DL, Shao X, Casadevall A, Husain S, Limaye AP,
Lyon M, Somani J, Pursell K, Pruett TL, Singh N: Serologic evidence
for reactivation of cryptococcosis in solid-organ transplant recipi-
ents. Clin Vaccine Immunol 2007, 14:1550–1554
5. Salyer WR, Salyer DC, Baker RD: Primary complex of Cryptococcus
and pulmonary lymph nodes. J Infect Dis 1974, 130:74–77
6. Miller KD, Mican JA, Davey RT: Asymptomatic solitary pulmonary
nodules due to Cryptococcus neoformans in patients infected with
human immunodeficiency virus. Clin Infect Dis 1996, 23:810–812
7. Jarvis JN, Wainwright H, Harrison TS, Rebe K, Meintjes G: Pulmo-
nary cryptococcosis misdiagnosed as smear-negative pulmonary
tuberculosis with fatal consequences. Int J Infect Dis 14(Suppl 3):
e310–e312
8. Pfeffer PE, Sen A, Das S, Sheaff M, Sivaramakrishnan A, Simcock
DE, Turner B: Eosinophilia, meningitis and pulmonary nodules in a
young woman. Thorax 65:1066, 1085
9. Zheng CF, Ma LL, Jones GJ, Gill MJ, Krensky AM, Kubes P, Mody
CH: Cytotoxic CD4 T cells use granulysin to kill Cryptococcus
neoformans, and activation of this pathway is defective in HIV pa-
tients. Blood 2007, 109:2049–2057
10. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis
W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, et al.: CD4 counts
as predictors of opportunistic pneumonias in human immunodefi-
ciency virus (HIV) infection. Ann Intern Med 1989, 111:223–231
11. French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, Lalloo
D, Whitworth JA, Gilks CF: Cryptococcal infection in a cohort of
HIV-1-infected Ugandan adults. AIDS 2002, 16:1031–1038
12. Arora S, Olszewski MA, Tsang TM, McDonald RA, Toews GB,
Huffnagle GB: Effect of cytokine interplay on macrophage polariza-
tion during chronic pulmonary infection with Cryptococcus neofor-
mans. Infect Immun 2011, 79:1915–1926
13. Chen GH, McNamara DA, Hernandez Y, Huffnagle GB, Toews GB,
Olszewski MA: Inheritance of immune polarization patterns is linked
to resistance versus susceptibility to Cryptococcus neoformans in a
mouse model. Infect Immun 2008, 76:2379–2391
14. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Worm-
ley FL Jr.: Pulmonary infection with an interferon-gamma-producing
Cryptococcus neoformans strain results in classical macrophage
activation and protection. Am J Pathol 2010, 176:774–785
15. Kawakami K, Tohyama M, Teruya K, Kudeken N, Xie Q, Saito A:
Contribution of interferon-gamma in protecting mice during pulmo-
nary and disseminated infection with Cryptococcus neoformans.
FEMS Immunol Med Microbiol 1996, 13:123–13016. Kawakami K, Tohyama M, Xie Q, Saito A: IL-12 protects mice
against pulmonary and disseminated infection caused by Crypto-
coccus neoformans. Clin Exp Immunol 1996, 104:208–214
17. Kawakami K, Kinjo Y, Yara S, Koguchi Y, Uezu K, Nakayama T,
Taniguchi M, Saito A: Activation of Valpha14() natural killer T cells
by alpha-galactosylceramide results in development of Th1 re-
sponse and local host resistance in mice infected with Cryptococ-
cus neoformans. Infect Immun 2001, 69:213–220
18. Uezu K, Kawakami K, Miyagi K, Kinjo Y, Kinjo T, Ishikawa H, Saito A:
Accumulation of gammadelta T cells in the lungs and their regulatory
roles in Th1 response and host defense against pulmonary infection
with Cryptococcus neoformans. J Immunol 2004, 172:7629–7634
19. Feldmesser M, Mednick A, Casadevall A: Antibody-mediated pro-
tection in murine Cryptococcus neoformans infection is associated
with pleotrophic effects on cytokine and leukocyte responses. Infect
Immun 2002, 70:1571–1580
20. Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski
LA: The absence of serum IgM enhances the susceptibility of mice
to pulmonary challenge with Cryptococcus neoformans. J Immunol
184:5755–5767
21. Yuan RR, Casadevall A, Oh J, Scharff MD: T cells cooperate with
passive antibody to modify Cryptococcus neoformans infection in
mice, Proc Natl Acad Sci U S A: 1997, 94:2483–2488
22. Hardison SE, Wozniak KL, Kolls JK, Wormley FL Jr.: IL-17 is not
required for classical macrophage activation in a pulmonary mouse
model of Cryptococcus neoformans infection. Infect Immun 2010,
78:5341–5351
23. Muller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, Schutze
N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber
G: IL-13 induces disease-promoting type 2 cytokines, alternatively
activated macrophages and allergic inflammation during pulmonary
infection of mice with Cryptococcus neoformans. J Immunol 2007,
179:5367–5377
24. Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB,
Toews GB, Huffnagle GB, Olszewski MA: Robust Th1 and Th17
immunity supports pulmonary clearance but cannot prevent sys-
temic dissemination of highly virulent Cryptococcus neoformans
H99. Am J Pathol 2009, 175:2489–2500
25. Kleinschek MA, Muller U, Brodie SJ, Stenzel W, Kohler G, Blumen-
schein WM, Straubinger RK, McClanahan T, Kastelein RA, Alber G:
IL-23 enhances the inflammatory cell response in Cryptococcus
neoformans infection and induces a cytokine pattern distinct from
IL-12. J Immunol 2006, 176:1098–1106
26. Kleinschek MA, Muller U, Schutze N, Sabat R, Straubinger RK,
Blumenschein WM, McClanahan T, Kastelein RA, Alber G: Admin-
istration of IL-23 engages innate and adaptive immune mechanisms
during fungal infection. Int Immunol 2010, 22:81–90
27. Wozniak KL, Hardison SE, Kolls JK, Wormley FL Jr.: Role of IL-17A
on Resolution of pulmonary C. neoformans infection. PLoS One
2011, 6:e17204
28. Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, Li D, Zhang G, Huang B,
Feng ZH: IL-17-producing alveolar macrophages mediate allergic
lung inflammation related to asthma. J Immunol 2008, 181:6117–
6124
29. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II,
Littman DR, O’Shea JJ: Lymphoid tissue inducer-like cells are an
innate source of IL-17 and IL-22. J Exp Med 2009, 206:35–41
30. Doisne JM, Soulard V, Becourt C, Amniai L, Henrot P, Havenar-
Daughton C, Blanchet C, Zitvogel L, Ryffel B, Cavaillon JM, Marie
JC, Couillin I, Benlagha K: Cutting edge: crucial role of IL-1 and
IL-23 in the innate IL-17 response of peripheral lymph node NK1.1-
invariant NKT cells to bacteria. J Immunol 2011, 186:662–666
31. Riol-Blanco L, Lazarevic V, Awasthi A, Mitsdoerffer M, Wilson BS,
Croxford A, Waisman A, Kuchroo VK, Glimcher LH, Oukka M: IL-23
receptor regulates unconventional IL-17-producing T cells that con-
trol bacterial infections, J Immunol 2010 184:1710–1720
32. Ciric B, El-behi M, Cabrera R, Zhang GX, Rostami A: IL-23 drives
pathogenic IL-17-producing CD8 T cells. J Immunol 2009, 182:
5296–5305
33. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL: Inter-
leukin-23 promotes a distinct CD4 T cell activation state character-
ized by the production of interleukin-17. J Biol Chem 2003, 278:
1910–1914
1558 Szymczak et al
AJP April 2012, Vol. 180, No. 434. Kimura A, Naka T, Kishimoto T: IL-6-dependent and -independent
pathways in the development of interleukin 17-producing T helper
cells. Proc Natl Acad Sci U S A 2007, 104:12099–12104
35. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat
C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C,
Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque
S: T cell interleukin-17 induces stromal cells to produce proinflam-
matory and hematopoietic cytokines. J Exp Med 1996, 183:2593–
2603
36. Hu Y, Ota N, Peng I, Refino CJ, Danilenko DM, Caplazi P, Ouyang W:
IL-17RC is required for IL-17A- and IL-17F-dependent signaling and
the pathogenesis of experimental autoimmune encephalomyelitis,
J Immunol 2010, 184:4307–4316
37. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzen-
berger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby
GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of
interleukin 17 receptor signaling for lung CXC chemokine and gran-
ulocyte colony-stimulating factor expression, neutrophil recruitment,
and host defense. J Exp Med 2001, 194:519–527
38. Rickel EA, Siegel LA, Yoon BR, Rottman JB, Kugler DG, Swart DA,
Anders PM, Tocker JE, Comeau MR, Budelsky AL: Identification of
functional roles for both IL-17RB and IL-17RA in mediating IL-25-
induced activities. J Immunol 2008, 181:4299–4310
39. Voelz K, Lammas DA, May RC: Cytokine signaling regulates the
outcome of intracellular macrophage parasitism by Cryptococcus
neoformans. Infect Immun 2009, 77:3450–3457
40. Rutitzky LI, Bazzone L, Shainheit MG, Joyce-Shaikh B, Cua DJ,
Stadecker MJ: IL-23 is required for the development of severe
egg-induced immunopathology in schistosomiasis and for lesional
expression of IL-17. J Immunol 2008, 180:2486–2495
41. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB, Oukka M,
Kuchroo VK: IL-21 initiates an alternative pathway to induce proin-
flammatory T(H)17 cells. Nature 2007, 448:484–487
42. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F,
Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M,
Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW,
Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA:
Novel p19 protein engages IL-12p40 to form a cytokine. IL-23, with
biological activities similar as well as distinct from IL-12. Immunity
2000, 13:715–725
43. Chamilos G, Ganguly D, Lande R, Gregorio J, Meller S, Goldman
WE, Gilliet M, Kontoyiannis DP: Generation of IL-23 producing den-
dritic cells (DCs) by airborne fungi regulates fungal pathogenicity
via the induction of T(H)-17 responses. PLoS One 2010, 5:e12955
44. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fu-
jikado N, Kusaka T, Kubo S, Chung SH, Komatsu R, Miura N, Adachi
Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito
T, Akira S, Iwakura Y: Dectin-2 recognition of alpha-mannans and
induction of Th17 cell differentiation is essential for host defense
against Candida albicans. Immunity 2010, 32:681–691
45. Siegemund S, Alber G: Cryptococcus neoformans activates bone
marrow-derived conventional dendritic cells rather than plasmacy-
toid dendritic cells and down-regulates macrophages. FEMS Immu-
nol Med Microbiol 2008, 52:417–427
46. Deepe GS Jr., Gibbons RS: Interleukins 17 and 23 influence the host
response to Histoplasma capsulatum. J Infect Dis 2009, 200:142–
151
47. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs
DM, Ghilardi N, deSauvage F, Cooper AM: IL-23 compensates for
the absence of IL-12p70 and is essential for the IL-17 response
during tuberculosis but is dispensable for protection and antigen-
specific IFN-gamma responses if IL-12p70 is available. J Immunol
2005, 175:788–795
48. Rudner XL, Happel KI, Young EA, Shellito JE: Interleukin-23 (IL-23)-
IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect
Immun 2007, 75:3055–3061
49. Kohyama S, Ohno S, Isoda A, Moriya O, Belladonna ML, Hayashi H,
Iwakura Y, Yoshimoto T, Akatsuka T, Matsui M: IL-23 enhances host
defense against vaccinia virus infection via a mechanism partly
involving IL-17. J Immunol 2007, 179:3917–3925
50. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A: IL-23 and
IL-17A, but not IL-12 and IL-22, are required for optimal skin host
defense against Candida albicans. J Immunol 185:5453–546251. Huffnagle GB, Boyd MB, Street NE, Lipscomb MF: IL-5 is required
for eosinophil recruitment, crystal deposition, and mononuclear cell
recruitment during a pulmonary Cryptococcus neoformans infection
in genetically susceptible mice (C57BL/6). J Immunol 1998, 160:
2393–2400
52. Maitta RW, Datta K, Chang Q, Luo RX, Witover B, Subramaniam K,
Pirofski LA: Protective and nonprotective human immunoglobulin M
monoclonal antibodies to Cryptococcus neoformans glucuronoxylo-
mannan manifest different specificities and gene use profiles. Infect
Immun 2004, 72:4810–4818
53. Guillot L, Carroll SF, Homer R, Qureshi ST: Enhanced innate immune
responsiveness to pulmonary Cryptococcus neoformans infection is
associated with resistance to progressive infection. Infect Immun
2008, 76:4745–4756
54. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB: CCR2 expression
determines T1 versus T2 polarization during pulmonary Cryptococ-
cus neoformans infection. J Immunol 2000, 164:2021–2027
55. Subramaniam KS, Datta K, Marks MS, Pirofski LA: Improved survival
of mice deficient in secretory immunoglobulin M following systemic
infection with Cryptococcus neoformans. Infect Immun 2010, 78:
441–452
56. Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB,
Huffnagle GB: Role of IFN-gamma in regulating T2 immunity and the
development of alternatively activated macrophages during allergic
bronchopulmonary mycosis. J Immunol 2005, 174:6346–6356
57. Meeks KD, Sieve AN, Kolls JK, Ghilardi N, Berg RE: IL-23 is required
for protection against systemic infection with Listeria monocyto-
genes. J Immunol 2009, 183:8026–8034
58. Yabu M, Shime H, Hara H, Saito T, Matsumoto M, Seya T, Akazawa
T, Inoue N: IL-23-dependent and -independent enhancement path-
ways of IL-17A production by lactic acid. Int Immunol 2011, 23:
29–41
59. Torchinsky MB, Garaude J, Martin AP, Blander JM: Innate immune
recognition of infected apoptotic cells directs T(H)17 cell differenti-
ation. Nature 2009, 458:78–82
60. Scurlock AM, Frazer LC, Andrews CW Jr., O’Connell CM, Foote IP,
Bailey SL, Chandra-Kuntal K, Kolls JK, Darville T:Interleukin-17 con-
tributes to generation of Th1 immunity and neutrophil recruitment
during Chlamydia muridarum genital tract infection but is not re-
quired for macrophage influx or normal resolution of infection. Infect
Immun 2011, 79:1349–1362
61. Roussel L, Houle F, Chan C, Yao Y, Berube J, Olivenstein R, Martin
JG, Huot J, Hamid Q, Ferri L, Rousseau S: IL-17 promotes p38
MAPK-dependent endothelial activation enhancing neutrophil re-
cruitment to sites of inflammation. J Immunol 184:4531–4537
62. Shahrara S, Pickens SR, Mandelin AM 2nd, Karpus WJ, Huang Q,
Kolls JK, Pope RM: IL-17-mediated monocyte migration occurs par-
tially through CC chemokine ligand 2/monocyte chemoattractant
protein-1 induction. J Immunol 2010, 184:4479–4487
63. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C:
Central role of immunoglobulin (Ig) E in the induction of lung eosin-
ophil infiltration and T helper 2 cell cytokine production: inhibition by
a non-anaphylactogenic anti-IgE antibody. J Exp Med 1996, 183:
1303–1310
64. Jain AV, Zhang Y, Fields WB, McNamara DA, Choe MY, Chen GH,
Erb-Downward J, Osterholzer JJ, Toews GB, Huffnagle GB, Olsze-
wski MA: Th2 but not Th1 immune bias results in altered lung
functions in a murine model of pulmonary Cryptococcus neoformans
infection. Infect Immun 2009, 77:5389–5399
65. Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC,
Casadevall A, Scharff MD: Immunoglobulin G monoclonal antibod-
ies to Cryptococcus neoformans protect mice deficient in comple-
ment component C3. Infect Immun 2002, 70:2598–2604
66. Guo L, Johnson RS, Schuh JC: Biochemical characterization of
endogenously formed eosinophilic crystals in the lungs of mice.
J Biol Chem 2000, 275:8032–8037
67. Liu Q, Cheng LI, Yi L, Zhu N, Wood A, Changpriroa CM, Ward JM,
Jackson SH: p47phox deficiency induces macrophage dysfunction
resulting in progressive crystalline macrophage pneumonia. Am J
Pathol 2009, 174:153–163
68. Arora S, McDonald RA, Toews GB, Huffnagle GB: Effect of a CD4-
depleting antibody on the development of Cryptococcus neofor-
mans-induced allergic bronchopulmonary mycosis in mice. Infect
Immun 2006, 74:4339–4348
The Role of IL-23 in Cryptococcosis 1559
AJP April 2012, Vol. 180, No. 469. Arora S, Huffnagle GB: Immune regulation during allergic broncho-
pulmonary mycosis: lessons taught by two fungi. Immunol Res 2005,
33:53–68
70. Peng J, Yang XO, Chang SH, Yang J, Dong C: IL-23 signaling
enhances Th2 polarization and regulates allergic airway inflamma-
tion. Cell Res 2010, 20:62–71
71. Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N,
Saito Y, Hatano M, Tokuhisa T, Iwakura Y, Puccetti P, Iwamoto I,
Nakajima H: IL-23 and Th17 cells enhance Th2-cell-mediated eosi-
nophilic airway inflammation in mice. Am J Respir Crit Care Med
2008, 178:1023–1032
72. Van Dyken SJ, Garcia D, Porter P, Huang X, Quinlan PJ, Blanc PD,
Corry DB, Locksley RM: Fungal chitin from asthma-associated home
environments induces eosinophilic lung infiltration. J Immunol 2011,
187:2261–2267
73. Moreira AP, Cavassani KA, Ismailoglu UB, Hullinger R, Dunleavy
MP, Knight DA, Kunkel SL, Uematsu S, Akira S, Hogaboam CM: The
protective role of TLR6 in a mouse model of asthma is mediated by
IL-23 and IL-17A. J Clin Invest 2011, 121:4420–4432
74. Piehler D, Stenzel W, Grahnert A, Held J, Richter L, Kohler G,
Richter T, Eschke M, Alber G, Muller U: Eosinophils contribute to
IL-4 production and shape the T-helper cytokine profile and in-
flammatory response in pulmonary cryptococcosis. Am J Pathol
2011, 179:733–744
75. Garro AP, Chiapello LS, Baronetti JL, Masih DT: Rat eosinophils
stimulate the expansion of Cryptococcus neoformans-specific
CD4() and CD8() T cells with a T-helper 1 profile. Immunology
2011, 132:174–187
76. Garro AP, Chiapello LS, Baronetti JL, Masih DT: Eosinophils elicit
proliferation of naive and fungal-specific cells in vivo so enhancing
a T helper type 1 cytokine profile in favour of a protective immune
response against Cryptococcus neoformans infection, Immunology
2011, 134:198–213
77. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M,
Peterson C, Seveus L, Trulson A: Eosinophil cationic protein (ECP):
molecular and biological properties and the use of ECP as a marker
of eosinophil activation in disease. Clin Exp Allergy 1999, 29:1172–
1186
78. Gundel RH, Letts LG, Gleich GJ: Human eosinophil major basic
protein induces airway constriction and airway hyperresponsive-
ness in primates. J Clin Invest 1991, 87:1470–1473
79. Fulkerson PC, Fischetti CA, McBride ML, Hassman LM, Hogan SP,
Rothenberg ME: A central regulatory role for eosinophils and the
eotaxin/CCR3 axis in chronic experimental allergic airway inflamma-
tion, Proc Natl Acad Sci U S A: 2006, 103:16418–16423
80. Hoenerhoff MJ, Starost MF, Ward JM: Eosinophilic crystalline pneu-
monia as a major cause of death in 129S4/SvJae mice. Vet Pathol
2006, 43:682–688
81. Ward JM: Pulmonary pathology of the motheaten mouse. Vet Pathol
1978, 15:170–178
82. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB,
Huffnagle GB: Distinct roles for IL-4 and IL-10 in regulating T2
immunity during allergic bronchopulmonary mycosis. J Immunol
2005, 174:1027–1036
83. Humphreys IR, Edwards L, Walzl G, Rae AJ, Dougan G, Hill S,
Hussell T: OX40 ligation on activated T cells enhances the control of
Cryptococcus neoformans and reduces pulmonary eosinophilia.
J Immunol 2003, 170:6125–6132
84. Ganzalo JA, Jia GQ, Aguirre V, Friend D, Coyle AJ, Jenkins NA, Lin
GS, Katz H, Lichtman A, Copeland N, Kopf M, Gutierrez-Ramos JC:
Mouse eotaxin expression parallels eosinophil accumulation during
lung allergic inflammation but it is not restricted to a Th2-type re-
sponse. Immunity 1996, 4:1–1485. Michels C, Goyal P, Nieuwenhuizen N, Brombacher F: Infection with
Syphacia obvelata (pinworm) induces protective Th2 immune re-
sponses and influences ovalbumin-induced allergic reactions. Infect
Immun 2006, 74:5926–5932
86. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N,
Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL,
Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI,
Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C,
Schaffer AA, Puck JM, Grimbacher B: STAT3 mutations in the hyper-
IgE syndrome. N Engl J Med 2007, 357:1608–1619
87. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Ander-
son V, Puck JM, Holland SM: Causes of death in hyper-IgE syn-
drome. J Allergy Clin Immunol 2007, 119:1234–1240
88. Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA,
Edgerton M, Gaffen SL: New mechanism of oral immunity to
mucosal candidiasis in hyper-IgE syndrome, Mucosal Immunol
2011, 4:448–455.
89. Minegishi Y: Hyper-IgE syndrome. Curr Opin Immunol 2009, 21:
487–492
90. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, Evans
RT, Gaffen SL: An essential role for IL-17 in preventing pathogen-
initiated bone destruction: recruitment of neutrophils to inflamed
bone requires IL-17 receptor-dependent signals. Blood 2007, 109:
3794–3802
91. Taborda CP, Rivera J, Zaragoza O, Casadevall A: More is not
necessarily better: prozone-like effects in passive immunization with
IgG. J Immunol 2003, 170:3621–3630
92. Yuan RR, Spira G, Oh J, Paizi M, Casadevall A, Scharff MD: Isotype
switching increases efficacy of antibody protection against Crypto-
coccus neoformans infection in mice. Infect Immun 1998, 66:1057–
1062
93. Schlageter AM, Kozel TR: Opsonization of Cryptococcus neofor-
mans by a family of isotype-switch variant antibodies specific for the
capsular polysaccharide. Infect Immun 1990, 58:1914–1918
94. Mukherjee S, Lee SC, Casadevall A: Antibodies to Cryptococcus
neoformans glucuronoxylomannan enhance antifungal activity of
murine macrophages. Infect Immun 1995, 63:573–579
95. Sanford JE, Lupan DM, Schlageter AM, Kozel TR: Passive immuni-
zation against Cryptococcus neoformans with an isotype-switch
family of monoclonal antibodies reactive with cryptococcal polysac-
charide. Infect Immun 1990, 58:1919–1923
96. Wormley FL JR., Perfect JR, Steele C, Cox GM: Protection against
cryptococcosis by using a murine gamma interferon-producing
Cryptococcus neoformans strain. Infect Immun 2007, 75:1453–1462
97. Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M,
Azuma M, Takeda K, Akira S, Saito A: Enhanced gamma interferon
production through activation of Valpha14() natural killer T cells by
alpha-galactosylceramide in interleukin-18-deficient mice with sys-
temic cryptococcosis. Infect Immun 2001, 69:6643–6650
98. Lindell DM, Moore TA, McDonald RA, Toews GB, Huffnagle GB:
Generation of antifungal effector CD8 T cells in the absence of
CD4 T cells during Cryptococcus neoformans infection. J Immunol
2005, 174:7920–7928
99. Guerrero A, Jain N, Wang X, Fries BC: Cryptococcus neoformans
variants generated by phenotypic switching differ in virulence
through effects on macrophage activation, Infect Immun 2010, 78:
1049–1057
100. Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J,
Musubire A, Lee SJ, Kambugu A, Janoff EN, Bohjanen PR: Clinical
features and serum biomarkers in HIV immune reconstitution inflam-
matory syndrome after cryptococcal meningitis: a prospective co-
hort study. PLoS Med 2010, 7:e1000384
